Shares of drug maker Forest Laboratories Inc. soared Friday, a day after a federal judge upheld a patent for the anti-depressant Lexapro.
Shares of Forest Labs rose $6, or 16 percent, to close at $44.40 on the New York Stock Exchange, near the high end of a 52-week range of $34.54 to $48.51.